Concepedia

Yujing Xin

YX

Statistics

Publications

18

Citations

551

H-Index

13

Active since

2018

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

First Hospital of Shanxi Medical University

Shanxi Medical University

National Cancer Center

Capital Medical University

Yujing Xin is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in medicine, oncology, and liver cancer.

Publications per year

2018–2024

18

Publications

18

Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study

Zhi‐Cheng Jin, Jian-Jia Chen, Xiaoli Zhu et al. · EClinicalMedicine · 2024 · 143 citations · Full text

, , +17

Efficacy and safety of lenvatinib plus PD-1 inhibitor with or without transarterial chemoembolization in unresectable hepatocellular carcinoma

Yujing Xin, Xinyuan Zhang, Ning Liu et al. · Hepatology International · 2023 · 59 citations

, , +16

Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk factors, patterns, and survival

Yi Yang, Yi Chen, Feng Ye et al. · European Radiology · 2020 · 51 citations

, , +17

Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma

Yujing Xin, Fei Cao, Hongcai Yang et al. · Frontiers in Immunology · 2022 · 47 citations · Full text

, , +15

A Systemic Inflammation Response Index (SIRI)-Based Nomogram for Predicting the Recurrence of Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation

Yujing Xin, Xinyuan Zhang, Ying Li et al. · CardioVascular and Interventional Radiology · 2021 · 27 citations

, , +13

1–5 of 18